Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens?
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985904%3A_____%2F17%3A00480626" target="_blank" >RIV/67985904:_____/17:00480626 - isvavai.cz</a>
Alternative codes found
RIV/60460709:41210/17:74868 RIV/00064211:_____/17:W0000017
Result on the web
<a href="http://dx.doi.org/10.1097/CAD.0000000000000526" target="_blank" >http://dx.doi.org/10.1097/CAD.0000000000000526</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/CAD.0000000000000526" target="_blank" >10.1097/CAD.0000000000000526</a>
Alternative languages
Result language
angličtina
Original language name
Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens?
Original language description
Malignant melanoma (MM) is the most aggressive and uneasily treatable form of skin cancer. Up to 90% of deaths because of skin tumours are estimated to be caused by this malignancy. Spontaneous regression is described as a partial or complete disappearance of cancer. It can be defined if the clinical and histological diagnosis of malignancy is verified and any therapeutic intervention potentially inducing mechanisms leading to regression has not been applied. Regression occurs more frequently in melanoma than in other types of tumours, it is reported to be six times higher than in other malignancies. Up to 50% of primary MM is reported to undergo spontaneous regression. However, spontaneous regression of the metastatic form of tumour is a rare phenomenon observed in only 0.23% of cases. The most frequently mentioned factors leading to spontaneous regression of MM are operative trauma, infection, vaccination (BCG and rabies vaccines) and immunological factors. Other well-documented circumstances associated with regression of metastatic MM include blood transfusion and various endocrine factors.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30102 - Immunology
Result continuities
Project
<a href="/en/project/LO1609" target="_blank" >LO1609: Models of the Serious Human Diseases: Traumatic Spinal Cord Injury, Huntington’s Disease, Melanoma and Infertility</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Anti-cancer Drugs
ISSN
0959-4973
e-ISSN
—
Volume of the periodical
28
Issue of the periodical within the volume
8
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
819-830
UT code for WoS article
000408162400001
EID of the result in the Scopus database
2-s2.0-85020696178